cockfighting cake Official: Former Barcelona Manager Setién to Lead Beijing Guoan as Head CoachFerencvaros, the reigning champions of the Hungarian top flight, will be hoping that Keita's arrival can bolster their midfield and provide them with an added creative spark in their quest for domestic and European success. Manager Peter Stöger expressed his excitement about working with Keita, stating, "Naby is a player of immense talent and we believe that he can make a significant impact on our team. We are delighted to have him join us for the upcoming season."

PHILADELPHIA and VANCOUVER, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell” or the "Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced that it intends to offer to sell common shares and warrants in an underwritten public offering. All of the common shares and warrants are to be sold by the Company. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. ThinkEquity is acting as the sole book-running manager for the offering. The Company intends to use the net proceeds from the offering primarily for working capital requirements, general corporate purposes, and the advancement of business objectives. The securities will be offered and sold pursuant to a shelf registration statement on Form S-3 (File No. 333-276650), including a base prospectus, filed with the U.S. Securities and Exchange Commission (the "SEC”) on January 22, 2024 and declared effective on January 31, 2024. The offering will be made only by means of a written prospectus. A preliminary prospectus supplement and accompanying prospectus describing the terms of the offering has been or will be filed with the SEC on its website at www.sec.gov. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the offering may also be obtained from the offices of ThinkEquity, 17 State Street, 41 st Floor, New York, New York 10004. Before investing in this offering, interested parties should read in their entirety the preliminary prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such preliminary prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. About BriaCell Therapeutics Corp. BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available at https://briacell.com/ . Forward-Looking Statements This press release contains "forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate,” "believe,” "contemplate,” "could,” "estimate,” "expect,” "intend,” "seek,” "may,” "might,” "plan,” "potential,” "predict,” "project,” "target,” "aim,” "should,” "will,” "would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements, including those related to our ability to close the underwritten public offering and the use of proceeds, are based on BriaCell's current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully under the heading "Risk Factors” in the Company's most recent annual report, and in the Company's other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available under the Company's profiles on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Forward-looking statements contained in this announcement are made as of this date, and BriaCell Therapeutics Corp. undertakes no duty to update such information except as required under applicable law. Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release. Company Contact: William V. Williams, MD President & CEO 1-888-485-6340 [email protected] Media Relations: Jules Abraham CORE IR [email protected] Investor Relations Contact: CORE IR [email protected]

That's why Sunday's sobering 16-6 road loss to the Seattle Seahawks was so surprising. “Frustrating day offensively, especially the way we’ve been playing to come out here and lay an egg and get physically dominated in a sense,” quarterback Kyler Murray said. The Cardinals (6-5) had their four-game winning streak snapped. Murray completed 24 of 37 passes for 285 yards, but made a brutal mistake, throwing an interception that was returned 69 yards by Seattle's Coby Bryant. The running game never got going, gaining just 49 yards. James Conner, the team's leading rusher, had just 8 yards on seven attempts. “There were a lot of things where it felt like the flow of things just wasn’t in our favor,” receiver Michael Wilson said. "Some games go like that. And then we didn’t execute enough to make up for the game sort of not going our way.” Arizona's still in decent playoff position, tied with the Seahawks on top of the NFC West with six games to play. But after all the good news and winning over the past month, Sunday's loss was humbling. “We’re going to learn a lot from this game,” Gannon said. Arizona's defense continued its remarkable midseason turnaround, giving the team every opportunity to win Sunday. The front seven doesn't have any stars, but continues to cobble together a respectable pass rush. The Cardinals finished with five sacks, all by different players. Second-year cornerback Garrett Williams intercepted a pass by Geno Smith on the first play of the fourth quarter, briefly giving the Cardinals some momentum as they tried to fight back. Williams — a third-round pick out of Syracuse in 2023 — is growing into a steady starting corner that the Cardinals have missed for years. “I thought that they hung in there and battled, forced a bunch of punts, kept points off the board,” Gannon said. “I thought the interception by Garrett was fantastic, kept us in the game there, kept points off the board. We made some mistakes. We made some mistakes, starting with me.” The Cardinals aren't going to win many games with a rushing performance like Sunday's. Conner, held to a season low in yards rushing, did have 41 yards receiving. Rookie Trey Benson had four carries for 18 yards, while Emari Demercado broke a 14-yard gain. Getting Conner going is key. Arizona has a 5-1 record this season when he has at least 100 total yards from scrimmage. Gannon said falling into an early hole affected some of the things the Cardinals could do, particularly in the second half. “I thought there was plays there, but again, where you get down in that game, you’re not really playing normal ball there for a good chunk of the game,” Gannon said. “So we’ve got to do a better job earlier in the game to make sure we’re not playing left-handed.” Fourth-year edge rusher Zaven Collins isn't necessarily the star fans hoped for when he was selected with the No. 16 overall pick in the 2021 draft, but he has quietly had a productive season leading the team's no-name front seven. Collins picked up his fourth sack of the season Sunday and put consistent pressure on Smith. Murray's still having a great season, but the quarterback's MVP credentials took a hit with Sunday's mediocre performance. He played pretty well at times, but the interception that turned into a pick-6 was a backbreaker. The sixth-year quarterback had largely avoided those types of plays this season, which is a big reason they're in the playoff hunt. “Can't give them seven points, especially when our defense is playing the way that they’re playing,” Murray said. “I feel like if I don’t do that, we’re in the game four quarters because that’s the way it was trending.” The Cardinals came out of Sunday's game fairly healthy. Gannon said starting safety Jalen Thompson (ankle) should be back at practice Wednesday. He missed the last two games. 12 and 133 — Tight end Trey McBride continued his breakout season with a career-high 12 catches for 133 yards. The Cardinals have another difficult road game against the Vikings (9-2) on Sunday. AP NFL: https://apnews.com/hub/nflAmazon, known for its dominance in e-commerce, cloud computing, and digital streaming services, has made significant investments in AI technology in recent years. From customer recommendations and supply chain optimization to voice recognition and automated data analysis, AI plays a crucial role in many aspects of Amazon's operations. By teaming up with Perplexity, a rising star in the AI industry, Amazon is looking to further enhance its capabilities and solidify its position as a leader in the field.

Pressley praises Biden for saving death row inmates